Ernest Tang, ctDNA Study Coordinator
Purpose of this study
Untreated lung cancer is a lethal disease and is the most common cancer diagnosed in both men and women in Canada.
This research study uses liquid biopsy technology with patient blood samples to assess for Lung Cancer circulating tumour DNA (ctDNA) and the impact on survival.
Who Can Participate?
Men and women aged 18 or older, that will have lung cancer treated with surgery.
The Lung ctDNA study is led by principal investigator Dr. A. McGuire (VGH Thoracic Surgery).